Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
- 27 August 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 34 (11), 3047-3049
- https://doi.org/10.1038/s41375-020-01030-2
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
This publication has 19 references indexed in Scilit:
- Detection of antibodies against SARS-CoV-2 in patients with COVID-19Journal of Medical Virology, 2020
- Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infectionJournal of Microbiology, Immunology and Infection, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Clinical Infectious Diseases, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Profile of specific antibodies to SARS-CoV-2: The first reportJournal of Infection, 2020
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)Clinical Infectious Diseases, 2020
- Perturbation of the normal immune system in patients with CLLBlood, 2015
- Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significanceRespirology, 2006
- Vaccination Against Infections in Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2003